7.5 Molecular Analysis of Pseudomonas Aeruginosa Virulence

Methods in Microbiology

Volumn 27, Issue C, 1998, Pages 383-393

  Yu, H ^a   Boucher, J C ^a   Deretic, V ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956655745     PISSN: 05809517     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0580-9517(08)70299-X     Document Type: Article

References (50)

1. Barry M.A., Lai W.C., and Johnston S.A. Protection against mycoplasma infection using expression-library immunization. Nature. 377 (1995) 632-635
2. Blackwood L.L., and Pennington J.E. Influence of mucoid coating on clearance of Pseudomonas aeruginosa from lungs. Infect. Immun. 32 (1981) 443-448
3. Boucher J.C., Martinez-Salazar J.M., Schurr M.J., Mudd M.H., Yu H., and Deretic V. Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA. J. Bacteriol. 178 (1996) 511-523
4. Cash H.A., Woods D.E., McCullough B., Johanson W.G., and Bass J.A. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev. Resp. Dis. 119 (1979) 453-459
5. Chi E., and Bartlett D.H. An rpoE-like locus controls outer membrane protein synthesis and growth at cold temperature and high pressures in the deepsea bacterium Photobacterium sp. strain SS9. Mol. Microbiol. 17 (1995) 713-726
6. Cryz S.J., Furer E., and Germanier R. Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice. Infect. Immun. 39 (1983) 1067-1071
7. Davidson D.J., Dorin J.R., McLachlan G., Ranaldi V., Lamb D., Doherty C., Govan J., and Porteous D.J. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nature Genet. 9 (1995) 351-357
8. De Lorenzo V., and Timmis K.N. Analysis and construction of stable phenotype in gram-negative bacteria with Tn5- and Tn1O-derived minitransposons. Methods Enzymol. 235 (1994) 386-405
9. Deretic V. In: Rappuoli R., Scarlato V., and Arico B. (Eds). Signal Transduction and Bacterial Virulence (1995), Landes, Austin, TX 43-60
10. Deretic V. In: Dodge J.A., Brock D.J.H., and Widdicombe J.H. (Eds). Cystic Fibrosis Current Topics 3 (1996), John Wiley & Sons, Chichester 223-244
11. Deretic V., Chandrasekharappa S., Gill J.F., Chatterjee D.K., and Chakrabarty A.M. A set of cassettes and improved vectors for genetic and biochemical characterization of Pseudomonas aeruginosa. Gene 57 (1987) 61-72
12. Deretic V., Schurr M.J., Boucher J.C., and Martin D.W. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J. Bacteriol. 176 (1994) 2773-2780
13. Deretic V., Pagan-Ramos E., Zhang Y., Dhandayuthapani S., and Via L.E. The exquisite sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid. Nature Biotech. 14 (1996) 1557-1561
14. Dhandayuthapani S., Via L.E., Thomas C.A., Horowitz P.M., Deretic D., and Deretic V. Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages. Mol. Microbiol. 17 (1995) 901-912
15. Fleishmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F., Kerlavage A.R., Bult C.J., Tomb J.F., Doughetry B.A., Merrick J.M., McKeenney K., Sutton G., FitzHugh W., Fields C., Gocayne J.D., Scott J., Shirley R., Lieu L.I., Glodek A., Kelley J.M., Weidman J.F., Phillips C.A., Spriggs T., Hedblom E., Cotton M.D., Utterback T.R., Hanna M.C., Nguyen D.T., Saudek D.M., Brandon R.C., Fine L.D., Fritchman J.L., Fuhrmann J.L., Georghagen N.S.M., Gnehm C.L., McDonald L.A., Small K.V., Fraser C.M., Smith H.O., and Venter J.C. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269 (1995) 496-512
16. Flynn J.L., and Ohman D.E. Use of a gene replacement cosmid vector for cloning alginate conversion genes from mucoid and nonmucoid Pseudomonas aeruginosa strains: algS controls expression of algT. J. Bacteriol. 170 (1988) 3228-3236
17. Gerke J.R., and Magliocco M.V. Experimental Pseudomonas aeruginosa infection of the mouse cornea. Infect. Immun. 3 (1981) 209-216
18. Govan J.R.W., and Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60 (1996) 539-574
19. Hatano K., Goldberg J.B., and Pier G.B. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Infect. Immun. 63 (1995) 21-26
20. Hazlett L.D., Rosen D.D., and Berk R.S. Pseudomonas eye infections in cyclophosphamide-treated mice. Invest. Ophthalmol. Vis. Sci. 16 (1977) 649
21. Hensel M., Shea J.E., Gleeson C., Jones M.D., Dalton E., and Holden D.W. Simultaneous identification of bacterial virulence genes by negative selection. Science 269 (1995) 400-403
22. LeClerc J.E., Li B., Payne W.L., and Cebula T.A. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274 (1996) 1208-1211
23. Mahan M.J., Slauch J.M., and Mekalanos J.J. Selection of bacterial virulence genes that are specially induced in host tissues. Science 259 (1993) 686-688
24. Martin D.W., Schurr M.J., Mudd M.H., Govan J.R.W., Holloway B.W., and Deretic V. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl Acad. Sci. USA 90 (1993) 8377-8381
25. Martin D.W., Holloway B.W., and Deretic V. Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor. J. Bacteriol. 175 (1993) 1153-1164
26. Mohr C.D., and Deretic V. Gene-scrambling mutagenesis: generation and analysis of insertional mutations in the alginate regulatory region of Pseudomonas aeruginosa. J. Bacteriol. 172 (1990) 6252-6260
27. Morissette C., Skarnene E., and Gervais F. Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice. Infect. Immun. 63 (1995) 1718-1724
28. Nicas T.I., and Iglewski B.H. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can. J. Microbiol. 31 (1985) 387-3921
29. Ochsner U.A., and Vasil M.L. Gene repression by the ferric uptake regulator in Pseudomonas aeruginosa: cycle selection of iron-regulated genes. Proc. Natl Acad. Sci. USA 93 (1996) 4409-4414
30. Olson J.C., McGuffie E.M., and Frank D.W. Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells. Infect. Immun. 65 (1997) 248-256
31. Passador L., Cook J.M., Gambello M.J., Rust L., and Iglewski B. Expression of Pseudomonas aeruginosa virulence factors requires cell-to-cell communication. Science 260 (1993) 1127-1130
32. Pier B.B., Meluleni G., and Neuger E. A murine model of chronic mucosal colonization by Pseudomonas aeruginosa. Infect. Immun. 60 (1992) 4768-4776
33. 24) heat shock sigma factor of Escherichia coli. EMBO J. 14 (1995) 1043-1055
34. Rehm S.R., Gross G.N., and Pierce A.K. Early bacterial clearance from murine lungs. J. Clin. Invest. 66 (1980) 194-199
35. Schweizer H.P., and Hoang T.T. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa. Gene 158 (1995) 15-22
36. Smith A.W., and Iglewski B.H. Transformation of Pseudomonas aeruginosa by electroporation. Nucleic Acids Res. 17 (1989) 10509
37. Sordelli D.O., Garcia V.E., Cerequetti C.M., Fontan P.A., and Hooke A.M. Intranasal immunization with temperature sensitive mutants protect granulocytopenic mice from lethal pulmonary challenge with Pseudomonas aeruginosa. Curr. Microbiol. 24 (1992) 9-14
38. Southern P.M., Pierce A.K., and Sanford J.P. Exposure chamber for 66 mice suitable for use with Henderson aerosol apparatus. Appl. Microbiol. 16 (1968) 540-542
39. Starke J.R., Edwards M.S., Langston C., and Baker C.J. A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr. Res. 22 (1987) 698-702
40. Stieritz D.D., and Holander I.A. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J. Infect. Dis. 131 (1975) 688-691
41. Tang H., Kays M., and Prince A. Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 63 (1995) 1278-1285
42. Toews G.B., Gross G.N., and Pierce A.K. The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice. Am. Rev. Resp. Dis. 120 (1979) 559-566
43. Wang J., Mushegian A., Lory S., and Jin S. Large-scale isolation of candidate virulence genes of Pseudomonas aeruginosa by in vivo selection. Proc. Natl Acad. Sci. USA 93 (1996) 10434-10439
44. Wretlind B., and Kronevi T. Experimental infections with protease-efficient mutants of Pseudomonas aeruginosa in mice. J. Med. Microbiol. 11 (1977) 145-154
45. Yahr T.L., Barbieri J.T., and Frank D.W. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa. J. Bacteriol. 178 (1996) 1412-1419
46. E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa. J. Bacteriol. 177 (1995) 3259-3268
47. Yu H., Boucher J.C., Hibler N.S., and Deretic V. Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (s). Infect. Immun. 64 (1996) 2774-2781
48. Yu H., Schurr M.J., Boucher J.C., Martinez-Salazar J.M., Martin D.W., and Deretic V. In: Silver S., Nakazowa T., and Haas D. (Eds). Molecular Biology of Pseudomonas (1996), ASM Press, Washington DC 384-397
49. H. Yu, M. Hanes. C.E. Chrisp, and J.C. Boucher, V. Deretic, (1998). Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge. Infect. Immun. (in press)
50. Zhang Y., Dhandayuthapani S., and Deretic V. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. Proc. Natl Acad. Sci. USA 93 (1996) 13212-13216